Clinical trials
Completed Phase 3 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UroGen Pharma Ltd. | 2 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cancer Institute (NCI) | 1 |
| Pfizer | 1 |
| Pierre Fabre Medicament | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 9 |
| Urinary Bladder Neoplasms | 5 |
| Urethral Neoplasms | 2 |
| Carcinoma | 1 |
| Non-Muscle Invasive Bladder Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
| Ureteral Neoplasms | 1 |
| Urologic Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.